The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
-
expand
A 24-week, multicentre, randomised, double-blind,age-stratified, placebo controlled phase III study with an 80-week extension period to evaluate the efficacy and safety of dapagliflozin 10 mg /day in patients with T2DM and cardiovascular disease, who exhibit inadequate glycaemic control on usual care
- Study Id
- D1690C00019
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Study Name
- D1690C00019
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Oct 13, 2011
-
expand
A 24-week, multicentre, randomised, double-blind, age-stratified, placebo controlled, phase III study with a 80-week extension period to evaluate the efficacy and safety of dapagliflozin 10 mg/day in pts with T2DM, CV disease and hypertension who exhibit inadequate glycaemic control on usual care
- Study Id
- D1690C00018
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Study Name
- D1690C00018
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Oct 13, 2011
-
expand
A 24-week,Multicentre,Randomised,Double-Blind,Placebo-Contr,Parallel-Group,International Phase III Study with 24week Extension to Evaluate the Safety and Efficacy of Dapagliflozin 10 mg/Day in patients with Type 2 Diabetes who have Inadequate Glyc Control on a DPP-4 inhibitor Sitagliptin+/-Metformin
- Study Id
- D1690C00010
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Study Name
- D1690C00010
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
May 28, 2012
-
expand
A 24-week international, randomized, parallel-group, double-blind, placebo-controlled Phase III study with a 24-week extension period to evaluate the efficacy and safety of dapagliflozin therapy when added to the therapy of patients with type 2 diabetes with inadequate glycaemic control on insulin
- Study Id
- D1690C00006
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Study Name
- D1690C00006
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Sep 16, 2010
-
expand
A 24-Week,Int.,Rand.,Double-blind,Parallel-group,Multi-centre, Plac.-controlled Phase III Study with a 24-Wk Ext.Per.to Eval.the Efficacy and Safety of Dapagliflozin in Comb.with Glimepiride (a Sulphonylurea) in Subjects with Type2 Diab.who Have Inadeq. Glycaemic Control on Glimepiride Therapy Alone
- Study Id
- D1690C00005
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Study Name
- D1690C00005
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Sep 7, 2012
-
expand
Drug-drug Interaction Study of Dapagliflozin With Voglibose in Japanese Type 2 Diabetes Mellitus Patients
- Study Id
- D1692C00002
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Study Name
- D1692C00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Aug 16, 2010
-
expand
An open label, randomized, two-period, crossover study to assess the effect of food on fixed dose combination dapagliflozin/metformin tablet (5 mg/1000 mg) in healthy male and female volunteers
- Study Id
- D1691C00005
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Study Name
- D1691C00005
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Dec 3, 2010
-
expand
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
- Study Id
- D1691C00002
- Disease
- diabetes mellitus
- Drug Name
- dapagliflozin
- Study Name
- D1691C00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Aug 4, 2010
-
expand
An epidemiological study to evaluate standard daily practice in managing patients with arterial hypertension and to evaluate patients’ quality of life
- Study Id
- NIS-CRS-DUM-2010/2
- Disease
- hypertension
- Drug Name
- non drug study (cardiovascular)
- Study Name
- NIS-CRS-DUM-2010/2
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jun 30, 2012
-
expand
A Randomised, Open Label, Parallel Group, Multicentre, Phase IV Study on the Effect of 8 Weeks Succinate Metoprolol (Betaloc ZOK®) (95 - 190 mg) on Heart Rate in the Stable Angina Patients
- Study Id
- D4022L00008
- Disease
- unstable angina pectoris
- Drug Name
- metoprolol succinate
- Study Name
- D4022L00008
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jul 10, 2012
